Nov 14 (Reuters) - Aralez Pharmaceuticals Inc ARZ.TO :
* Aralez pharmaceuticals -new post-hoc analysis supports yosprala efficacy and safety in previous heart attack patients who need daily aspirin therapy Source text for Eikon: Further company coverage: ARZ.TO